Distress and depression in cancer patients - diagnosis and treatment
Journal Title: OncoReview - Year 2012, Vol 2, Issue 4
Abstract
Cancer diagnosis destroys previous internal and external order of patient, who has not experienced such a situation yet. The most negative emotions, which are felt in the situation of cancer diagnoses are anxiety, sadness, anger, distress and concern about the continued existence and functionality, which can also lead to depression. It becomes essential to identify the grade of bigger distress and depression, which increase suffering of the patient, reduce the effectiveness of therapy, as well as significantly raise the risk of suicide among cancer patients. Article presents general assumptions related to the epidemiology of distress and depression in cancer, diagnostic and range of possible therapies that can be used to treat cancer patients.
Authors and Affiliations
Anna Kieszkowska-Grudny
Keywords
Related Articles
- EP ID EP53180
- DOI -
- Views 246
- Downloads 0
Rehabilitation of patients with cancer of the respiratory system
Many patients with lung cancer have concomitant chronic obstructive pulmonary disease and heart diseases. The planned anticancer therapy should be individualized in relationship of patient’s cardiac and pulmonary conditi...
Analysis of 7965 screening colonoscopies and treatment results of detected colorectal cancers – experiences of one center
Introduction: Colorectal cancer is one of the most common cancers in both sexes and is one of the leading causes of death in Poland and the world. An effective method to prevent the development of colorectal cancer (CRC)...
Cisplatin-induced cardiotoxicity – two case reports
Cisplatin has been used for over 40 years in various cancer chemotherapies. Toxicity induced by cisplatin-based therapeutic regimens include gastrointestinal toxicity, myelotoxicity, neurotoxicity, ototoxicity and nephro...
Nefrotoksyczność leków stosowanych w chemioterapii nowotworów
Rozwój onkologii klinicznej oraz coraz częstsza zapadalność na nowotwory powodują szybkie zwiększanie się grupy chorych leczonych chemioterapeutykami. Stosowanie tych leków oprócz korzyści niesie ze sobą również ryzyko w...
Superior efficacy of nilotinib vs imatinib in patients with chronic myeloid leukemia in chronic phase. ENESTnd and ENESTcmr current results analysis
Second generation tyrosine kinase inhibitors can improve the efficacy of treatment and outcome in newly diagnosed patients with chronic myeloid leukemia in chronic phase. The primary endpoint of ENESTnd trial is the comp...